Navigation Links
Physicians and Patients Across Texas Decry Trend of Unauthorized Generic Drug Substitutions
Date:3/12/2008

AUSTIN, Texas, March 12 /PRNewswire/ -- A growing trend is emerging across Texas as more and more patients discover that their prescriptions have been switched to generic versions of brand-name medications without their knowledge or prior consent. The movement has also alarmed many physicians, who state that they are deliberate in their decision to prescribe a specific medication and emphasize the danger of substitutions being made without their knowledge.

The reasons for switching medications are varied and can sometimes be confusing to a patient. Many insurance companies have an institutional policy of encouraging patients and physicians to substitute medications within the same drug class based solely on cost considerations. Also, generic medications are typically available at a lower co-payment level which, in turn, leads the consumer to believe they are receiving the same course of treatment prescribed by their doctor while saving money. This, unfortunately, is not always the case and many safety issues have arisen as a result of this practice.

"Undetected medication switching is a source of major stress among patients," Dr. Randeep Suneja of Houston, said. "We're finding that as a growing number of patients take an active and educated role in their treatment options, many are concerned that with generic medications, they aren't receiving the optimum formulation required to properly address their medical condition."

Depending on the situation, substitution is often decided at the pharmacy counter because of a patient decision or due to the patient's healthcare plan dictating certain requirements for formulary coverage.

The topic of switching has reached the national stage and as a result, more than half of the 50 state Attorneys General have weighed in on the issue. Earlier this month, Texas Attorney General Greg Abbott announced that his office had settled a lawsuit that requires a major pharmacy benefits manager to inform patients and drug prescribers about the effect a switch to a generic will have on the patient's co-payment, and what financial incentives the benefits manager will realize for initiating a drug switch. Abbott's office also ruled that benefits managers must notify patients and prescribers that a patient can be reimbursed for out-of-pocket expenses associated with drug-switching, and that patients have the right to decline the drug switch.

Education, coupled with an acute awareness of what is prescribed versus what is being dispensed by a pharmacist, is paramount to ensure that a patient receives the recommended treatment their physician desires. A host of resources are available on this topic and many experts speak frequently about drug switching. For more information, or to see the variety of opinions on brand-name drugs and their distinct benefits, please visit American Medical Association's site at http://www.ama-assn.org/ama/pub/category/17730.html or the American College of Cardiology's position statement at http://www.acc.org/qualityandscience/clinical/stc/therapeutic.htm

Contact: Kevin Smothers or Meg Meo

Elizabeth Christian & Associates Public Relations, 512-472-9599

ksmothers@echristianpr.com or mmeo@echristianpr.com


'/>"/>
SOURCE Dr. Randeep Suneja
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
3. Psychiatrists are the least religious of all physicians
4. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
5. Scientists, physicians present latest findings in personalized cancer treatment and prevention
6. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
7. U.S. Physicians Question Presidential Candidates
8. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
9. Internal medicine physicians recommend key elements to guide state initiatives
10. Fingertip Formulary Mobile(TM) is Now Available for Physicians and Other Healthcare Providers Free on PDAs
11. American College of Physicians publishes The Fenway Guide to LGBT Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... The National Business ... National Registry of Emergency Medical Technicians and welcomes this organization to ... Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at NBRI. “This ...
(Date:4/26/2017)... ... 26, 2017 , ... RawTrition now brings you BioEnergy which is a powder ... , RawTrition is taking nutrients to the next level! The superfoods ... its raw form (unlike the synthetically made options that are on the market). , ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... an agile ecosystem and domain expertise for sponsors and CROs to speed ... trial supply management (RTSM) software platform. Bioclinica AGILE RTSM provides ...
(Date:4/25/2017)... CA (PRWEB) , ... April 25, 2017 , ... ... access, support, and collaboration, announces Mirroring360 Pro . This new addition to ... comprehensive collaboration experience for education and business. , Mirroring360 Pro enables educators, business ...
(Date:4/25/2017)... ... 2017 , ... A stressful work environment can hurt the physical and emotional ... performance in the workplace. The goal of Clearview Resolution Services has always been to ... Clearview Resolution Services will be shutting down the office early on Fridays. The Clearview ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global Surgical ... devices are tubes used to remove excess liquid and ... serum, pus, urine, bile or lymph. Surgical drains are ... surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic ... prophylactic post-surgery to prevent accumulation of fluid e.g. blood ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: